Quantum BioPharma closes CAD 4 million private placement tranche

Quantum Biopharma Ltd. Subordinate Voting Shares Class B +7.80%

Quantum Biopharma Ltd. Subordinate Voting Shares Class B

QNTM

3.52

+7.80%

  • Quantum BioPharma closed an initial tranche of a private placement and issued 3,750 debenture units for CAD 3.8 million.
  • One director subscribed for CAD 300,000 of debenture units in the offering.
  • Separately, the company issued 370,457 Class B subordinate voting shares to settle about CAD 1.1 million of debt.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief on March 20, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.